Nina Mayr, MD, FASTRO, FAAAS

Locations of Practice

Overview

Dr. Nina Mayr is a professor in the Department of Radiation Oncology at the University of Washington. Dr. Mayr specializes in the treatment of women’s cancers, lung cancer, neuro-oncology, and tumor imaging.

Patient Care Philosophy

Whatever we do in medicine—clinical care, teaching, research, outreach, leadership—it has one purpose: to improve our patients’ health, well-being and lives. To me, patients come first, always and everyday.

Education and Training

Medical Education: Ludwig-Maximilians-Universität, Munich, Germany, 1985

Residency: University of Iowa Hospitals and Clinics, Iowa City, IA, 1990

Fellowship: University of Iowa Hospitals and Clinics, Iowa City, IA, 1993

Selected Publications from a Total of 174

Dad L, Royce TJ, Morris Z, Moran M, Pawlicki T, Khuntia D, Hardenbergh P, ummings B, Mayr N, Hu K. Bridging innovation and outreach to overcomecome global gaps in radiation oncology through information and communication tools, trainee advancement, engaging industry, attention to ethical challenges, and political advocacy. Sem Radiat Oncol. 2017 Apr; 27(2): 98–108.

Norbash A, Yucel K, Yuh W, Doros G, Ajam A, Lang E, Pauker S, Mayr N. Effect of team training on improving MRI study completion rates and no-show rates. J Magn Reson Imaging. 2016 Oct;44(4):1040-7.

Lo SS, Foote M, Siva S, Slotman BJ, Teh BS, Guckenberger M, Tan D, Mayr NA, Sahgal A. Technical know-how in stereotactic ablative radiotherapy (SABR). J Med Radiat Sci. 2016 Mar; 63(1):5-8.

Xu-Welliver M, Yuh WT, Fielding JR, Macura KJ, Huang Z, Ayan AS, Backes FJ, Jia G, Zhang J, Mayr NA. Imaging Across the Lifespan: Innovations in Imaging and Therapy for Gynecologic Cancer. Radiographics. 2014 Jul; 34(4):1062-1081. From publication 7/2014 to 12/2014, this article generated 233 CME certificates.

Lo SS, Sahgal A, Chang EL, Mayr NA, The BS, Huang Z, Schefter TE, Yao Machtay M, Slotman B, Timmerman RD. Serious complications associated with stereotactic ablative radiotherapy (SABR) and strategies to mitigate the risk. Clin Oncol (R Coll Radiol). 2013 Jun; 25(6):378-87.

Lo SS, Teh BS, Mayr NA, Chiang SB, Huang Z, Yao M, Machay M. Imaging follow-up after stereotactic ablative radiotherapy (SABR) for lung tumors. J Radiat Oncol (JRON). 2012 Feb; 1(1): 11-16.

Mayr NA, Huang Z, Wang JZ, Lo SS, Fan JM, Grecula JC, Sammet S, Sammet CL, Guang J, Zhang J, Knopp MV, Yuh WTC. Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model. Int J Radiat Oncol Biol Phys. 2012 Jul ; 83(3): 972-9.

Wang JZ, Huang Z, Lo SS, Yuh WTC, Mayr NA. A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy and high-dose-rate brachytherapy. Science Transl Med. 2010 Jul; 2(39): 39ra48.

Mayr NA, Wang JZ, Zhang D, Grecula JC, Lo SS, Jarjoura D, Montebello JF, Zhang H, Li K, Lu L, Huang Z, Fowler JM, Wu DH, Knopp MV, Yuh WTC. Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical cancer. Int J Radiat Oncol Biol Phys. 2010 Jun; 77: 502-508.

Mayr NA, Wang JZ, Lo SS, Zhang D, Grecula JC, Lu L, Montebello JF, Fowler JM, Yuh WTC. Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer. Int J Radiat Oncol Biol Phys. 2010 Mar; 76 (3): 719-727.